BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38265792)

  • 1. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
    Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
    JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability.
    Ahlqvist VH; Sjöqvist H; Dalman C; Karlsson H; Stephansson O; Johansson S; Magnusson C; Gardner RM; Lee BK
    JAMA; 2024 Apr; 331(14):1205-1214. PubMed ID: 38592388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children.
    Suarez EA; Bateman BT; Hernández-Díaz S; Straub L; Wisner KL; Gray KJ; Pennell PB; Lester B; McDougle CJ; Zhu Y; Mogun H; Huybrechts KF
    JAMA Intern Med; 2022 Oct; 182(11):1149-60. PubMed ID: 36190722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study.
    Straub L; Hernández-Díaz S; Bateman BT; Wisner KL; Gray KJ; Pennell PB; Lester B; McDougle CJ; Suarez EA; Zhu Y; Zakoul H; Mogun H; Huybrechts KF
    JAMA Intern Med; 2022 May; 182(5):522-533. PubMed ID: 35343998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes.
    Taipale H; Bergström J; Gèmes K; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
    JAMA Netw Open; 2024 Mar; 7(3):e242859. PubMed ID: 38506810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The causal association between maternal depression, anxiety, and infection in pregnancy and neurodevelopmental disorders among 410 461 children: a population study using quasi-negative control cohorts and sibling analysis.
    Hope H; Pierce M; Gabr H; Radojčić MR; Swift E; Taxiarchi VP; Abel KM
    Psychol Med; 2024 Jun; 54(8):1693-1701. PubMed ID: 38205522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study.
    Njotto LL; Simin J; Fornes R; Odsbu I; Mussche I; Callens S; Engstrand L; Bruyndonckx R; Brusselaers N
    Drug Saf; 2023 May; 46(5):467-478. PubMed ID: 37087706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada.
    Hossin MZ; de la Cruz LF; McKay KA; Oberlander TF; Sandström A; Razaz N
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38150596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management.
    O'Connor L; Carbone S; Gobbo A; Gamble H; Faraone SV
    Expert Rev Clin Pharmacol; 2023; 16(9):799-812. PubMed ID: 37587841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts.
    Alemany S; Avella-García C; Liew Z; García-Esteban R; Inoue K; Cadman T; López-Vicente M; González L; Riaño Galán I; Andiarena A; Casas M; Margetaki K; Strandberg-Larsen K; Lawlor DA; El Marroun H; Tiemeier H; Iñiguez C; Tardón A; Santa-Marina L; Júlvez J; Porta D; Chatzi L; Sunyer J
    Eur J Epidemiol; 2021 Oct; 36(10):993-1004. PubMed ID: 34046850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
    Huybrechts KF; Bröms G; Christensen LB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad Ø; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Bateman BT
    JAMA Psychiatry; 2018 Feb; 75(2):167-175. PubMed ID: 29238795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate Use During Spermatogenesis and Risk to Offspring.
    Christensen J; Trabjerg BB; Dreier JW
    JAMA Netw Open; 2024 Jun; 7(6):e2414709. PubMed ID: 38833248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children.
    Nielsen TC; Nassar N; Shand AW; Jones H; Guastella AJ; Dale RC; Lain SJ
    JAMA Pediatr; 2021 Mar; 175(3):e205487. PubMed ID: 33464287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
    Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
    JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population based cohort study.
    Choi A; Lee H; Jeong HE; Lee SY; Kwon JS; Han JY; Choe YJ; Shin JY
    BMJ; 2024 May; 385():e076885. PubMed ID: 38777351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders.
    Chen VC; Wu SI; Lin CF; Lu ML; Chen YL; Stewart R
    JAMA Netw Open; 2022 Nov; 5(11):e2243282. PubMed ID: 36413366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium.
    Kurth L; O'Shea TM; Burd I; Dunlop AL; Croen L; Wilkening G; Hsu TJ; Ehrhardt S; Palanisamy A; McGrath M; Churchill ML; Weinberger D; Grados M; Dabelea D
    J Neurodev Disord; 2024 May; 16(1):26. PubMed ID: 38796448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Neurodevelopmental Disorders in Offspring of Mothers With Eating Disorders in Sweden.
    Mantel Ä; Örtqvist AK; Hirschberg AL; Stephansson O
    JAMA Netw Open; 2022 Jan; 5(1):e2143947. PubMed ID: 35040968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental Complications Associated With Psychostimulant Use in Pregnancy.
    Cohen JM; Hernández-Díaz S; Bateman BT; Park Y; Desai RJ; Gray KJ; Patorno E; Mogun H; Huybrechts KF
    Obstet Gynecol; 2017 Dec; 130(6):1192-1201. PubMed ID: 29112657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.